Clinical Study
Consumption of High-Polyphenol Dark Chocolate Improves Endothelial Function in Individuals with Stage 1 Hypertension and Excess Body Weight
Table 3
Metabolic variables and biomarkers of inflammation and oxidative stress at baseline (week 0) and at the end of the study (week 4).
| | Variable | Week 0
() | Week 4
() | |
| | Glucose (mg/dL) | 90.60 ± 2.60 | 88.65 ± 2.75 | 0.55 | | Insulin (U/mL) | 21.86 ± 3.11 | 23.49 ± 2.94 | 0.19 | | HOMA-IR | 4.94 ± 0.79 | 5.08 ± 0.63 | 0.20 | | Total cholesterol (mg/dL) | 199.00 ± 7.41 | 195.15 ± 9.25 | 0.55 | | HDL cholesterol (mg/dL) | 50.85 ± 2.31 | 48.75 ± 2.64 | 0.43 | | LDL cholesterol (mg/dL) | 122.15 ± 6.71 | 122.00 ± 9.24 | 0.98 | | Triglycerides (mg/dL) | 132.80 ± 11.18 | 122.55 ± 11.77 | 0.29 | | High sensitive CRP (mg/dL) | 0.93 ± 0.27 | 0.61 ± 0.12 | 0.24 | | Tumor necrosis factor- (pg/mL) | 17.51 ± 8.03 | 18.96 ± 9.02 | 0.18 | | Interleucine-6 (pg/mL) | 87.87 ± 20.6 | 69.40 ± 14.7 | 0.17 | | Oxidized LDL (g/mL) | 0.11 ± 0.01 | 0.12 ± 0.01 | 0.60 |
|
|
Values are expressed as mean ± standard error.
HDL: high-density lipoprotein, LDL: low density lipoprotein, CRP: C-reactive protein.
|
